Therapy-related, donor-derived AML responding to a second allogeneic BMT [1]

Bone Marrow Transplantation

Volumn 40, Issue 5, 2007, Pages 499-500

  Jacobs, J F M ^a   Brons, P P ^a   Simons, A ^a   van der Reijden, B A ^a   Hoogerbrugge, P M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MERCAPTOPURINE; METHOTREXATE; TENIPOSIDE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; CASE REPORT; CAUCASIAN; CYTOGENETICS; DONOR; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; BONE MARROW TRANSPLANTATION; CYTOGENETIC ANALYSIS; GENE REARRANGEMENT; HUMANS; INFANT; LEUKEMIA, MYELOID; LEUKEMIA, PRE-B-CELL; MALE; NEOPLASMS, SECOND PRIMARY; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548065275     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705750     Document Type: Letter

References (8)

1. Reichard KK, Zhang QY, Sanchez L, Hozier J, Viswanatha D, Foucar K. Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: Case report and review of the literature. Am J Hematol 2006; 81: 178-185.
2. Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S et al. Development of leukemia in donor cells after allogeneic stem cell transplantation - a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2005; 90: 969-975.
3. Maas F, Schaap N, Kolen S, Zoetbrood A, Buno I, Dolstra H et al. Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms. Leukemia 2003; 17: 621-629.
4. Ng A, Taylor GM, Wynn RF, Eden OB. Effects of topoisomerase 2 inhibitors on the MLL gene in children receiving chemotherapy: A prospective study. Leukemia 2005; 19: 253-259.
5. Sung PA, Libura J, Richardson C. Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: New insights and new questions. DNA Repair (Amst) 2006; 5: 1109-1118.
6. Felix CA. Leeukemias related to treatment with DNA topoisomerase II inhibitors. Med Pediatr Oncol 2001; 36: 525-535.
7. Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med 1999; 341: 1051-1062.
8. Komrokji R, Ifthikharuddin JJ, Felgar RE, Abboud CN, Wedow LA, Connaughton A et al. Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: Case report and literature review. Am J Hematol 2004; 76: 389-394.